课题基金 / 基金详情

"CONTRACT ORIENTATION AND KICKOFF MEETING", TASK ORDER #1 UNDER 75N91019D00012. TASK ORDER PERIOD OF PERFORMANCE: 1/25/2019-2/24/2019.

"CONTRACT ORIENTATION AND KICKOFF MEETING", TASK ORDER #1 UNDER 75N91019D00012. TASK ORDER PERIOD OF PERFORMANCE: 1/25/2019-2/24/2019.
“合同说明会和启动会议”,任务顺序
批准号:
10019025
负责人:
DAVID MCCORMICK
金额:
$0.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-25 至 2019-02-24

项目摘要

项目成果

DAVID MCCORMICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As per Contract requirements, the Contractor will participate in the initial parent contract kick-off meeting to be held at the NCI in Maryland. The kick-off meeting shall be attended by the Principal Investigator, key Contractor technical and business staff, the COR and his/her designees, and the Contracting Officer and/or his/her designees. Program Staff will present details and requirements of the PREVENT program and respond to any questions Contractors may have regarding management of the IDIQ Base Contracts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
  • 批准号:
    10932479
  • 项目类别:
  • 资助金额:
    $65.95万
  • 财政年份:
    2023
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIO
  • 批准号:
    10710462
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2022
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
  • 批准号:
    10802090
  • 项目类别:
  • 资助金额:
    $145.68万
  • 财政年份:
    2022
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
  • 批准号:
    10605054
  • 项目类别:
  • 资助金额:
    $75.0万
  • 财政年份:
    2022
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
海外基金